Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
| Autor: | Shari Goldfarb, Chau T. Dang, Maura N. Dickler, Tiffany A. Troso-Sandoval, Clifford A. Hudis, Neil M. Iyengar, Tiffany A. Traina, P. Defusco, A. Latif, Diana Lake, Monica Fornier, Jasmeet Chadha Singh, Ayca Gucalp, Komal Jhaveri, L. Smyth, J. Baselga, Shanu Modi, Larry Norton, G. Ulaner, M. Jochelson |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty business.industry Phases of clinical research Hematology medicine.disease Metastatic breast cancer 03 medical and health sciences Gemcitabine/Trastuzumab 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Pertuzumab business medicine.drug |
| Zdroj: | Annals of Oncology. 27:vi84 |
| ISSN: | 0923-7534 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|